Knockdown of OTUD5 has been reported to significantly promote the proliferation of HCC cells (Huh7 and Hep3B), and reduced levels of OTUD5 are associated with a highly invasive phenotype and poor clinical outcome and may play an oncogene role in a variety of solid tumors [71]. This evidence concerns the gene OTUD5 and hepatocellular carcinoma.